Valenti L - Search Results

1

PCSK9 rs11591147 R46L loss-of-function variant protects against liver damage in individuals with NAFLD.

Grimaudo S, Bartesaghi S, Rametta R, Marra F, Margherita Mancina R, Pihlajamäki J, Kakol-Palm D, Andréasson AC, Dongiovanni P, Ludovica Fracanzani A, Lori G, Männistö V, Pellegrini G, Bohlooly-Y M, Pennisi G, Maria Pipitone R, Spagnuolo R, Craxì A, Lindén D, Valenti L, Romeo S, Petta S. Grimaudo S, et al. Among authors: valenti l. Liver Int. 2021 Feb;41(2):321-332. doi: 10.1111/liv.14711. Epub 2020 Nov 2. Liver Int. 2021. PMID: 33091218

2

Tumor necrosis factor alpha promoter polymorphisms influence the phenotypic expression of hereditary hemochromatosis.

Fargion S, Valenti L, Dongiovanni P, Scaccabarozzi A, Fracanzani AL, Taioli E, Mattioli M, Sampietro M, Fiorelli G. Fargion S, et al. Among authors: valenti l. Blood. 2001 Jun 15;97(12):3707-12. doi: 10.1182/blood.v97.12.3707. Blood. 2001. PMID: 11389006 Free article.

3

Tumor necrosis factor alpha promoter polymorphisms and insulin resistance in nonalcoholic fatty liver disease.

Valenti L, Fracanzani AL, Dongiovanni P, Santorelli G, Branchi A, Taioli E, Fiorelli G, Fargion S. Valenti L, et al. Gastroenterology. 2002 Feb;122(2):274-80. doi: 10.1053/gast.2002.31065. Gastroenterology. 2002. PMID: 11832442

4

Increased susceptibility to nonalcoholic fatty liver disease in heterozygotes for the mutation responsible for hereditary hemochromatosis.

Valenti L, Dongiovanni P, Fracanzani AL, Santorelli G, Fatta E, Bertelli C, Taioli E, Fiorelli G, Fargion S. Valenti L, et al. Dig Liver Dis. 2003 Mar;35(3):172-8. doi: 10.1016/s1590-8658(03)00025-2. Dig Liver Dis. 2003. PMID: 12779071

5

TNFalpha promoter polymorphisms.

Fargion S, Valenti L, Dongiovanni P, Fracanzani AL. Fargion S, et al. Among authors: valenti l. Methods Mol Med. 2004;98:47-58. doi: 10.1385/1-59259-771-8:047. Methods Mol Med. 2004. PMID: 15064432

6

Searching for coeliac disease in patients with non-alcoholic fatty liver disease.

Bardella MT, Valenti L, Pagliari C, Peracchi M, Farè M, Fracanzani AL, Fargion S. Bardella MT, et al. Among authors: valenti l. Dig Liver Dis. 2004 May;36(5):333-6. doi: 10.1016/j.dld.2004.01.012. Dig Liver Dis. 2004. PMID: 15191202

7

The mitochondrial superoxide dismutase A16V polymorphism in the cardiomyopathy associated with hereditary haemochromatosis.

Valenti L, Conte D, Piperno A, Dongiovanni P, Fracanzani AL, Fraquelli M, Vergani A, Gianni C, Carmagnola L, Fargion S. Valenti L, et al. J Med Genet. 2004 Dec;41(12):946-50. doi: 10.1136/jmg.2004.019588. J Med Genet. 2004. PMID: 15591282 Free PMC article.

8

TNFalpha genotype affects TNFalpha release, insulin sensitivity and the severity of liver disease in HCV chronic hepatitis.

Valenti L, Pulixi E, Fracanzani AL, Dongiovanni P, Maggioni M, Orsatti A, Gianni C, Fargion S. Valenti L, et al. J Hepatol. 2005 Dec;43(6):944-50. doi: 10.1016/j.jhep.2005.05.035. Epub 2005 Jul 5. J Hepatol. 2005. PMID: 16143422

9

Iron and insulin resistance.

Fargion S, Dongiovanni P, Guzzo A, Colombo S, Valenti L, Fracanzani AL. Fargion S, et al. Among authors: valenti l. Aliment Pharmacol Ther. 2005 Nov;22 Suppl 2:61-3. doi: 10.1111/j.1365-2036.2005.02599.x. Aliment Pharmacol Ther. 2005. PMID: 16225476

10

Alpha 1-antitrypsin mutations in NAFLD: high prevalence and association with altered iron metabolism but not with liver damage.

Valenti L, Dongiovanni P, Piperno A, Fracanzani AL, Maggioni M, Rametta R, Loria P, Casiraghi MA, Suigo E, Ceriani R, Remondini E, Trombini P, Fargion S. Valenti L, et al. Hepatology. 2006 Oct;44(4):857-64. doi: 10.1002/hep.21329. Hepatology. 2006. PMID: 17006922

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

591 results

Search Page

Filters